Aimei Health Technology Co Ltd（AFJK）の財務AFJKAimei Health Technology Co Ltd

Evaluating the bottom line, Aimei Health Technology Co Ltd maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of 1.66%, provide a clear picture of how effectively AFJK converts its operational activities into shareholder value.

In the context of the broader market, AFJK competes directly with industry leaders such as OGCP and THCH. With a market capitalization of $38.67M, it holds a significant position in the sector. When comparing efficiency, AFJK's gross margin of N/A stands against OGCP's N/A and THCH's 56.21%. Such benchmarking helps identify whether Aimei Health Technology Co Ltd is trading at a premium or discount relative to its financial performance.

The company has shown inconsistent financial performance, with a recent net income of -83,144 USD in Q2 2026 and a declining trend in EPS, which fell to -0.03.